June 2019

Utilization Management Changes

Brand Name

Corresponding Generic Name

Strength

UM Change

Common Use

BELBUCA

buprenorphine hcl

75, 150, 300, 450, 600, 750, 900 MCG FILM

ST removed

Moderate-to-severe pain

LATUDA

lurasidone hcl

20, 40, 60, 80, 120 MG TABLET

ST removed

Schizophrenia, bipolar disorder

RANEXA ER

ranolazine

500, 1,000 MG TABLET

ST removed

Chronic angina

Legal Disclaimer | Privacy | Product Disclosures | Cigna Company Names

Health benefit plans vary, but in general to be eligible for coverage a drug must be approved by the Food and Drug Administration (FDA), prescribed by a health care professional, purchased from a licensed pharmacy and medically necessary. Some plans require you to use an in-network pharmacy for prescriptions to be covered. Coverage is subject to any plan deductible, copayment and/or coinsurance requirements. Product availability may vary by location and plan type and is subject to change. All group health insurance policies and health benefit plans contain exclusions and limitations. For costs and details of coverage, contact a Cigna representative. Group medical and pharmacy plans are insured and/or administered by Cigna Health and Life Insurance Company or its affiliates. Policy forms: OK - HP-APP-1 et al., OR - HP-POL38 02-13, TN - HP-POL43/HC-CER1V1 et al. All pictures are used for illustrative purposes only. This website is not intended for residents of New Mexico.

© 2019 Cigna. All rights reserved